Skip to main content
Premium Trial:

Request an Annual Quote

New Products: HTG Molecular's Edge DMPK and TOA Assays

Premium

Tucson, Ariz.-based HTG Molecular Diagnostics this week announced the availbility of two new multiplexed assays for drug and oncology research.

The 47-gene Edge DMPK Assay enables researchers to characterize drug metabolism in pre-clinical studies. The company also released its Edge TOA Assay, which measures the expression levels of 32 of the most commonly assayed oncogenes in fresh or fixed biological specimens.

Both new offerings rely on HTG's quantitative nuclease protection assay, or qNPA, technology, and are processed using its automated Edge system for gene expression profiling of formalin-fixed, paraffin-embedded samples.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.